Exenatide
What is Exenatide?
The first GLP-1 receptor agonist to market (Byetta, Bydureon), derived from a compound in Gila monster venom.
It is now essentially historical in weight management, but it is the reason the class exists at all.
Related reading: EXSCEL: The Large Neutral Result
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Exenatide comes up on this site
On GLP Watchdog, Exenatide comes up in 8 research articles.
Research that discusses it
- GLP-1 Drugs and Parkinson's Disease: What LIXIPARK and Exenatide-PD3 Showed
- Exenatide (Byetta, Bydureon): The First GLP-1, Its Weight Loss and Where It Went
- Generic GLP-1s: Eleven for Liraglutide, and None You Can Buy for Semaglutide
- FDA-Approved Peptides: The Verified List, and What Is Not on It
- GLP-1 Drugs and Lipedema: What Semaglutide and Tirzepatide Studies Show
- Blood Thinners and a GLP-1: Warfarin, Eliquis, Xarelto With Ozempic or Mounjaro
- All 8 articles are on the research page
Connected terms
Other terms under drug
Where the evidence lives
- The full GLP-1 glossary (150 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers